Adlai Nortye USA Inc

ACTIVE

685 US Highway 1, North Brunswick, New Jersey, United StatesPrivate

Clinical Trials

6 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

77.8%

Phase 3

11.1%

Trial Status Distribution

Active, not recruiting

66.7%

Recruiting

33.3%

Clinical Trials

Trials sponsored by this organization (9)

The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone in patients with head and neck cancer

Phase 1

Recruiting

interventional

Nov 2021483 participants

The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone in patients with head and neck cancer

Phase 1

Active, not recruiting

Sep 2021489 participants

The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone in patients with head and neck cancer

Phase 1

Active, not recruiting

Aug 2021489 participants

The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone in patients with head and neck cancer

Phase 1

Recruiting

interventional

Jul 2021483 participants

The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Active, not recruiting

interventional

Jul 2021483 participants

The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone in patients with head and neck cancer

Phase 1

Active, not recruiting

Mar 2021489 participants

A trial to investigate the safety and tolerability of E7046 when it is given together with radiation and chemotherapy before surgery in patients who have rectum cancer.

Phase 1

Active, not recruiting

Jun 201735 participants

A trial to investigate the safety and tolerability of E7046 when it is given together with radiation and chemotherapy before surgery in patients who have rectum cancer.

Phase 1

Active, not recruiting

Jan 201735 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations